ANGPharmaceuticals

AngloGold Ashanti plcQuarterly Results & Earnings

18.42
-5.71%
Profit Growth YoY-41.15%Latest quarter
Sales Growth YoY-20.77%Latest quarter
Sales CAGR 5YN/A5 year compound
Profit CAGR 5YN/A5 year compound
📋

Quarterly Performance

YoY Profit Growth-41.15%
🔴 Significant decline
YoY Sales Growth-20.77%
🔴 Significant decline
OPM 5Y Average
Operating profit margin
10.94%
EPS Growth 5Y
N/A
Interest Coverage
Higher = safer debt servicing
-0.96
ROE
-17.05%
ROCE
-4.18%
💡

Growth Analysis

AngloGold Ashanti plc reported YoY profit growth of -41.15% and revenue growth of -20.77% in the latest quarter. Significant profit decline — requires close monitoring. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.